Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors × apatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 11 Stomach Neoplasms 6 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Ovarian Neoplasms 2 Liver Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Advanced Gastric Cancer 2 Adenocarcinoma 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Limited Stage 1 Small Cell Lung Cancer Extensive Stage 1 Salivary Gland Neoplasms 1 Radioactive Iodine-refractory Differentiated Thyroid Cancer 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Malignant Neoplasms of Digestive Organs 1 Gestational Trophoblastic Disease 1 Gastric Adenocarcinoma 1 Fludzoparib" and Anti-angiogenic 1 Colonic Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Advanced Biliary Tract Carcinoma 1 Adrenocortical Carcinoma 1 Adrenal Gland Neoplasms 1 Adebrelimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡